NIOX Group (LON:NIOX) Shares Down 0.6% – Time to Sell?

NIOX Group Plc (LON:NIOX) shares dropped 0.6% during trading on Thursday . The stock traded as low as GBX 67.55 and last traded at GBX 68.20. 202,489 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 831,375 shares. The stock had previously closed at GBX 68.60.

NIOX Group Trading Down 0.3%

The business has a 50 day moving average of GBX 61.84 and a two-hundred day moving average of GBX 61.21. The company has a debt-to-equity ratio of 1.36, a quick ratio of 1.94 and a current ratio of 3.81. The firm has a market capitalization of £286.19 million, a price-to-earnings ratio of 41.46 and a beta of 0.92.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.